← Insider buys

MILLENNIUM MANAGEMENT LLC has bought SNSE on 3 days since Mar 2026

10% owner at Faeth Therapeutics, Inc.

SEC CIK 0001273087 · Filings on SEC.gov ↗

$1.3MBought
$538KSold
May 15Last buy

MILLENNIUM MANAGEMENT LLC's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

4 filings since May 2026, newest first

About MILLENNIUM MANAGEMENT LLC

Millennium Management LLC is a global, diversified alternative investment management firm and multistrategy hedge fund, operating as one of the world’s largest alternative asset managers with approximately $84.2 billion in assets under management as of March 2026.( Founded in 1989 by Israel A. Englander and Ronald Shear with $35 million in capital, the firm has grown into a major institutional platform spanning the Americas, Europe, and Asia, with its principal office in New York and primary regional offices in financial centers including London, Dubai, Singapore, Miami, Bengaluru, Tel Aviv, Tokyo, Dublin, Greenwich, Geneva, Zug, and Paris.( Millennium is recognized for its multi-manager, multi-strategy platform model, employing hundreds of investment teams across relative value, fundamental equity, event-driven, and quantitative strategies to pursue attractive risk-adjusted returns for its investors.(

As a corporate insider and 10% owner at Sensei Biotherapeutics, Inc. (SNSE), Millennium Management acts in its capacity as an institutional investment manager, taking significant positions as part of its broader portfolio of public-market investments. The firm is led by its founder Israel A. Englander, who serves as a key figure in its strategic direction, and it emphasizes a client-centric culture, rigorous risk management, and a collaborative, talent-driven environment.( Through its scale, global footprint, and platform structure, Millennium continues to be a prominent and influential participant in global capital markets, including in the biotechnology sector where it maintains sizable holdings such as its stake in Sensei Biotherapeutics.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.